Lung biopsies in infants and children in critical care situation

Yaël Levy1, Lauren Bitton2, Chiara Sileo3

  • 1Pediatric and neonatal intensive care unit, Armand Trousseau Hospital, APHP, Sorbonne University, Paris, France.

Pediatric Pulmonology
|January 2, 2024
PubMed

Insights

Lung biopsy is a reliable diagnostic tool for critically ill neonates with suspected lung developmental disorders. Complications were mainly associated with extracorporeal membrane oxygenation (ECMO).

Area of Science:

  • Pediatric critical care medicine
  • Pulmonology
  • Diagnostic procedures

Background:

  • Lung biopsy is an invasive diagnostic tool for lung diseases.
  • Its use in critically ill pediatric patients requires careful consideration of risks and benefits.

Purpose of the Study:

  • To evaluate the diagnostic yield of lung biopsy in critically ill pediatric patients.
  • To assess diagnostic reliability across different age groups.
  • To identify complications associated with lung biopsy in this population.

Main Methods:

  • Retrospective review of pediatric patients undergoing lung biopsy in the ICU between 1995 and 2022.
  • Exclusion of biopsies performed in the operating room and post-mortem.
  • Analysis of diagnostic yield, reliability by age, and complication rates.

Main Results:

  • 31 patients included; 67.7% were newborns. 81% of biopsies yielded a diagnosis.
  • Diagnostic reliability was highest in newborns (95%) and decreased with age.
  • Diffuse developmental lung disorders (49%) were the most common diagnosis. Complications occurred in 29% of patients, primarily hemorrhages in those on ECMO.

Conclusions:

  • Lung biopsy is a reliable diagnostic procedure for critically ill neonates with suspected diffuse developmental lung disorders.
  • Complications are significantly associated with extracorporeal membrane oxygenation (ECMO).
  • Further prospective evaluation of complications in specific subgroups (e.g., prolonged ECMO, older children) is warranted.
Abstract